SCOPUS 정보 검색 플랫폼

Volumn 159, Issue 2, 2012, Pages 161-162

Is there a need for adjusting the results of the recent meta-analysis on the novel oral anticoagulants in atrial fibrillation to the baseline CHADS 2 score?

(1) Providência, Rui a,b

a CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA (Portugal)

b UNIVERSITY OF COIMBRA (Portugal)

Author keywords

Apixaban; Atrial fibrillation; Dabigatran; Novel oral anticoagulants; Rivaroxaban; Warfarin

Indexed keywords

ANTICOAGULANT AGENT; APIXABAN; DABIGATRAN; RIVAROXABAN;

BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CHADS2 SCORE; CORRELATION COEFFICIENT; DEATH; DRUG EFFICACY; DRUG SAFETY; HAZARD RATIO; HEART ATRIUM FIBRILLATION; HUMAN; LETTER; META ANALYSIS; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PATIENT CODING; PRIORITY JOURNAL; RISK ASSESSMENT; RISK REDUCTION; SCORING SYSTEM; STROKE;

EID: 84864991230 PISSN: 01675273 EISSN: 18741754 Source Type: Journal
DOI: 10.1016/j.ijcard.2012.05.047 Document Type: Article

Times cited : (3)

References (7)

1
- 84863981277
- Meta-analysis of efficacy and safety of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus warfarin in patients with atrial fibrillation
- C.S. Miller, S.M. Grandi, A. Shimony, K.B. Filion, and M.J. Eisenberg Meta-analysis of efficacy and safety of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus warfarin in patients with atrial fibrillation Am J Cardiol 110 3 2012 453 460
- (2012) Am J Cardiol , vol.110 , Issue.3 , pp. 453-460
- Miller, C.S.¹ Grandi, S.M.² Shimony, A.³ Filion, K.B.⁴ Eisenberg, M.J.⁵

2
- 84881477376
- Novel oral anticoagulants versus warfarin in non-valvular atrial fibrillation: A meta-analysis of 50,578 patients
- 10.1016/j.ijcard.2012.03.148
- D. Capodanno, P. Capranzano, G. Giacchi, V. Calvi, and C. Tamburino Novel oral anticoagulants versus warfarin in non-valvular atrial fibrillation: a meta-analysis of 50,578 patients Int J Cardiol Apr 9 2012 10.1016/j.ijcard.2012. 03.148
- (2012) Int J Cardiol
- Capodanno, D.¹ Capranzano, P.² Giacchi, G.³ Calvi, V.⁴ Tamburino, C.⁵

3
- 70349306707
- Dabigatran versus warfarin in patients with atrial fibrillation
- S.J. Connolly, M.D. Ezekowitz, and S. Yusuf Dabigatran versus warfarin in patients with atrial fibrillation N Engl J Med 361 12 Sep 17 2009 1139 1151
- (2009) N Engl J Med , vol.361 , Issue.12 , pp. 1139-1151
- Connolly, S.J.¹ Ezekowitz, M.D.² Yusuf, S.³

4
- 80052825103
- Apixaban versus warfarin in patients with atrial fibrillation
- C.B. Granger, J.H. Alexander, and J.J. McMurray Apixaban versus warfarin in patients with atrial fibrillation N Engl J Med 365 11 Sep 15 2011 981 992
- (2011) N Engl J Med , vol.365 , Issue.11 , pp. 981-992
- Granger, C.B.¹ Alexander, J.H.² McMurray, J.J.³

5
- 80052592404
- Rivaroxaban versus warfarin in nonvalvular atrial fibrillation
- M.R. Patel, K.W. Mahaffey, and J. Garg Rivaroxaban versus warfarin in nonvalvular atrial fibrillation N Engl J Med 365 10 Sep 8 2011 883 891
- (2011) N Engl J Med , vol.365 , Issue.10 , pp. 883-891
- Patel, M.R.¹ Mahaffey, K.W.² Garg, J.³

6
- 80955182268
- Risks for stroke, bleeding, and death in patients with atrial fibrillation receiving dabigatran or warfarin in relation to the CHADS2 score: A subgroup analysis of the RE-LY trial
- [W204]
- J. Oldgren, M. Alings, and H. Darius Risks for stroke, bleeding, and death in patients with atrial fibrillation receiving dabigatran or warfarin in relation to the CHADS2 score: a subgroup analysis of the RE-LY trial Ann Intern Med 155 10 Nov 15 2011 660 667 [W204]
- (2011) Ann Intern Med , vol.155 , Issue.10 , pp. 660-667
- Oldgren, J.¹ Alings, M.² Darius, H.³

7
- 77957884628
- Ethics in the authorship and publishing of scientific articles
- L.G. Shewan, and A.J. Coats Ethics in the authorship and publishing of scientific articles Int J Cardiol 144 2010 1 2
- (2010) Int J Cardiol , vol.144 , pp. 1-2
- Shewan, L.G.¹ Coats, A.J.²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.